We are live on ! Find out more
NTRP

Neurotrope, Inc. Common
NTRP

Delisted

NTRP was delisted on the 1st of December, 2020.

28 hedge funds and large institutions have $1.75M invested in Neurotrope, Inc. Common in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

173% more call options, than puts

Call options by funds: $90K | Put options by funds: $33K

115% more capital invested

Capital invested by funds: $811K → $1.75M (+$935K)

33% more funds holding

Funds holding: 2128 (+7)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

Holders
28
Holders Change
+7
Holders Change %
+33.33%
% of All Funds
0.62%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
10
Increased
4
Reduced
6
Closed
2
Calls
$90K
Puts
$33K
Net Calls
+$57K
Net Calls Change
+$40K
Name Holding Trade Value Shares
Change
Change in
Stake
CM
26
Caption Management
Oklahoma
-$6K -6,200 Closed
Wells Fargo
27
Wells Fargo
California
+$72 +66 New
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
+$390 +358 New

NTRP Hedge Fund Activity: Q1 2020 in Review

28 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Neurotrope, Inc. Common (NTRP) for Q1 2020, worth a combined $1.75M — up 115% from $811K a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new NTRP positions and 2 closed out — a net gain of 8 holders — while 4 added to existing stakes and 6 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $933K. The largest seller was Group One Trading, cutting an estimated $32.1K.

  • 28 institutional investors held Neurotrope, Inc. Common (NTRP) as of Q1 2020, up from 21 in Q4 2019.
  • Funds reported $1.75M of Neurotrope, Inc. Common stock for Q1 2020, up 115% quarter-over-quarter.
  • 10 funds opened new Neurotrope, Inc. Common positions in Q1 2020 and 2 closed out, a net change of +8 holders.
  • The largest Neurotrope, Inc. Common buyer in Q1 2020 was Anson Funds Management, an estimated $933K added.
  • The largest Neurotrope, Inc. Common seller in Q1 2020 was Group One Trading, an estimated $32.1K sold.

Based on aggregated 13F filings for Q1 2020.